Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 7 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| Advisorshares Psychedelics ETF | PSIL | AMEX | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.2911 | 04:41:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.2911 |
| Trades | Etfs Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 2 | 7 | - | 1.20 - 2.249 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 03:53:47 | 6 | 2.04 | USD |
Advisorshares Psychedelics ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.26M | - | - | - | 50.62 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Advisorshares Psychedeli...
Real-Time news about Advisorshares Psychedelics ETF (American Stock Exchange): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PSIL Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.23 | 1.30 | 1.21 | 1.27 | 42,227 | 0.0611 | 4.97% |
| 1 Month | 1.55 | 1.57 | 1.20 | 1.36 | 71,929 | -0.2589 | -16.70% |
| 3 Months | 1.42 | 1.70 | 1.20 | 1.46 | 74,458 | -0.1289 | -9.08% |
| 6 Months | 1.47 | 1.70 | 1.20 | 1.44 | 61,063 | -0.1789 | -12.17% |
| 1 Year | 1.72 | 2.249 | 1.20 | 1.56 | 46,127 | -0.4289 | -24.94% |
| 3 Years | 10.10 | 10.70 | 1.20 | 2.85 | 34,216 | -8.81 | -87.22% |
| 5 Years | 10.10 | 10.70 | 1.20 | 2.85 | 34,216 | -8.81 | -87.22% |
| The AdvisorShares Psychedelics ETF (the Fund) seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and (ii) derivatives that have economic characteristics similar to such securities. The Fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The Fund invests in exchange-listed equity securities, including common and preferred stock of U.S. and foreign mid, small and micro-capitalization companies, and in total return swaps intended to provide exposure to such companies. |
